The 77th Scientific Congress & Expo of the American Society for Reproductive Medicine (ASRM) has just culminated last October 21 at the Baltimore Convention Center in the “Charm City” of Baltimore, Maryland, USA after running for 5 days. With the theme “Reproduction Reimagined”, the congress was successfully reinterpreted after its absence last year due to the Covid pandemic.

ASRM, an institution devoted to creating innovative changes in the field of reproductive medicine science and practice, designed a program to address the educational and practice needs of physicians, nurses, andrology and embryology laboratory personnel, genetic counselors, mental health practitioners, practice managers, as well as practitioners in public health, allied health, law, and ethics.

Some of the highlights from the 77th edition of the ASRM include:

  • Hands-on courses on “Embryo Transfer Simulation” (a course that focused on perfecting embryo transfer techniques using models ranging in levels of difficulty); and SRS Surgical hands-on course “The Art of Perfecting Myomectomies”.
  • One of the most notable plenary speakers this year was Dr. Jennifer Doudna, who received the 2020 Nobel Prize in Chemistry for her pioneering work with CRISPR gene editing.
  • A celebration of the the 40th anniversary of the 1st US IVF baby looking at the past, present and future of IVF.
  • Dr. Marcelle Cedars was sworn in as the new president of the American Society for Reproductive Medicine effective October 20, 2021. Dr. Cedars is a professor and the Director of the Division of Reproductive Endocrinology at the University of California, San Francisco.
  • One of the major highlights of the scientific congress presented is the three studies on “Infertility Treatments Remained Strong with Good Outcomes In Spite Of Covid-19”. It is true that the COVID-19 pandemic interrupted a lot of healthcare aspects and caused temporary barriers to traditional care, leading to questions about the impact of the pandemic on fertility and assisted reproductive treatments (ART). Nonetheless, the results of the 3 studies presented indicates that with appropriate provisions, results before and during the pandemic stayed to be similar in several aspects of infertility care – including egg retrieval and IVF cycles.

Esco Medical, the fertility technologies division of the Esco Lifesciences Group, successfully participated as one of the major exhibitors in the annual event. It was during this time that Esco Medical was able to showcase its limited-edition MIRI® II-12 multiroom incubator. Other Esco Medical products that were exhibited include: MIRI® and its stacking frame, the new MIRI® Humidity (a 6-chambered multiroom incubator that works on wet culture); a Multi-zone ART Workstation (MAW), a new product in the form of a warming table for physicians tool, and the MIRI® Time-Lapse incubator (both the 6 and 12 chambers).

In behalf of Esco Technologies, Inc and the entire Esco Medical team, we want to send out our utmost gratitude to everyone who came to check on and inquire about our products. We hope that this year’s event was able to build and sustain our harmonious relationship together. ‘Til next year!